- Home
- Daniel Bromage
Daniel Bromage
Department of Cardiovascular Sciences, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine, Faculty of Life Sciences and Medicine, King’s College London, London, UK
Biography
Dr Daniel Bromage is Clinical Senior Lecturer at King’s College London and Honorary Consultant Cardiologist at King’s College Hospital NHS Foundation Trust, London, UK.
He completed a PhD at University College London in 2016, funded by the MRC, exploring stromal derived factor-1 in cardioprotection. He later held an NIHR Clinical Lectureship studying post-myocardial infarction remodelling, focusing on leucocyte recruitment. As an MRC Clinician Scientist Fellow, he investigated inflammation regulation after infarction using transcriptomic techniques. His research interests include heart failure, cardio-immunology and myocarditis.
Featured Courses
- 1.00
Published:
Learning objectives
- Define residual inflammatory risk (RIR) and explain why cardiovascular events continue to occur in patients despite optimal lipid-lowering and antihypertensive therapies
- Describe the pathophysiological role of inflammation in atherosclerosis, myocardial infarction, heart failure and chronic kidney disease
- Identify patients at increased cardiovascular risk due to elevated inflammatory markers, particularly high-sensitivity C-reactive protein (hsCRP)
- Interpret the clinical significance of hsCRP and other inflammatory biomarkers in primary and secondary prevention settings, in alignment with current evidence and guideline recommendations
- Assess clinician practices, barriers and strategies for integrating inflammatory risk assessment and management
- Apply key takeaways to inform future risk assessment and treatment decisions in patients with or at risk for cardiovascular disease